应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MLYS Mineralys Therapeutics, Inc.
盘前交易 05-02 06:37:48 EDT
12.80
+0.55
+4.49%
最高
13.53
最低
12.41
成交量
36.99万
今开
12.41
昨收
12.25
日振幅
9.14%
总市值
6.35亿
流通市值
2.94亿
总股本
4,963万
成交额
478.60万
换手率
1.61%
流通股本
2,299万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Mineralys Therapeutics, Inc.盘中异动 快速上涨5.06%报12.87美元
自选股智能写手 · 00:09
Mineralys Therapeutics, Inc.盘中异动 快速上涨5.06%报12.87美元
Mineralys Therapeutics, Inc.盘中异动 临近午盘股价大涨5.30%报11.73美元
自选股智能写手 · 04-23
Mineralys Therapeutics, Inc.盘中异动 临近午盘股价大涨5.30%报11.73美元
Mineralys Therapeutics, Inc.盘中异动 急速跳水5.00%报12.36美元
自选股智能写手 · 04-16
Mineralys Therapeutics, Inc.盘中异动 急速跳水5.00%报12.36美元
Mineralys Therapeutics, Inc.盘中异动 早盘快速上涨5.16%报13.66美元
自选股智能写手 · 04-08
Mineralys Therapeutics, Inc.盘中异动 早盘快速上涨5.16%报13.66美元
Mineralys Therapeutics, Inc.盘中异动 早盘急速上涨5.08%
自选股智能写手 · 04-05
Mineralys Therapeutics, Inc.盘中异动 早盘急速上涨5.08%
Mineralys Therapeutics, Inc.2023财年实现净利润-71.90百万美元,同比减少141.28%
自选股智能写手 · 03-22
Mineralys Therapeutics, Inc.2023财年实现净利润-71.90百万美元,同比减少141.28%
Mineralys Therapeutics, Inc.盘中异动 下午盘快速下挫5.15%报12.70美元
自选股智能写手 · 03-22
Mineralys Therapeutics, Inc.盘中异动 下午盘快速下挫5.15%报12.70美元
Mineralys Therapeutics, Inc.盘中异动 股价大涨5.39%报13.29美元
自选股智能写手 · 03-19
Mineralys Therapeutics, Inc.盘中异动 股价大涨5.39%报13.29美元
Mineralys Therapeutics, Inc.盘中异动 股价大跌5.09%
自选股智能写手 · 03-12
Mineralys Therapeutics, Inc.盘中异动 股价大跌5.09%
Mineralys Therapeutics, Inc.盘中异动 大幅下挫5.00%
自选股智能写手 · 03-07
Mineralys Therapeutics, Inc.盘中异动 大幅下挫5.00%
Mineralys Therapeutics Inc盘中异动 下午盘股价大跌5.00%
自选股智能写手 · 02-29
Mineralys Therapeutics Inc盘中异动 下午盘股价大跌5.00%
Mineralys Therapeutics Inc盘中异动 快速下跌5.50%
自选股智能写手 · 02-13
Mineralys Therapeutics Inc盘中异动 快速下跌5.50%
Mineralys Therapeutics Inc盘中异动 早盘快速拉升5.06%报14.74美元
自选股智能写手 · 02-09
Mineralys Therapeutics Inc盘中异动 早盘快速拉升5.06%报14.74美元
Mineralys Therapeutics Inc股价上涨17.28% 市值涨1.04亿美元
自选股智能写手 · 02-08
Mineralys Therapeutics Inc股价上涨17.28% 市值涨1.04亿美元
Mineralys Therapeutics Inc盘中异动 股价大涨5.87%报11.55美元
自选股智能写手 · 02-02
Mineralys Therapeutics Inc盘中异动 股价大涨5.87%报11.55美元
Mineralys Therapeutics Inc盘中异动 急速跳水5.05%
自选股智能写手 · 01-29
Mineralys Therapeutics Inc盘中异动 急速跳水5.05%
Mineralys Therapeutics Inc盘中异动 早盘急速拉升5.49%
自选股智能写手 · 01-25
Mineralys Therapeutics Inc盘中异动 早盘急速拉升5.49%
Mineralys Therapeutics Inc盘中异动 大幅上涨5.08%报9.93美元
自选股智能写手 · 01-25
Mineralys Therapeutics Inc盘中异动 大幅上涨5.08%报9.93美元
Mineralys Therapeutics Inc盘中异动 临近收盘股价大涨5.03%
自选股智能写手 · 01-24
Mineralys Therapeutics Inc盘中异动 临近收盘股价大涨5.03%
加载更多
公司概况
公司名称:
Mineralys Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Mineralys Therapeutics, Inc.最初成立于2019年5月31日,是特拉华州的一家公司。该公司是一家临床阶段生物制药公司,专注于开发药物,以治疗由异常升高的醛固酮引起的疾病。该公司的候选产品氯隆前列素是一种专有的口服高选择性醛固酮合酶抑制剂(ASI),该公司最初开发用于治疗未控制的高血压(uHTN)患者,定义为尽管服用了两种或多种抗高血压药物或抵抗性高血压(rHTN),但血压仍不能达到130/80mmHg以下的个体。在美国,有超过1.15亿患者患有持续性高血压(BP)或高血压,超过一半的患者未能实现血压目标,即目前可用的药物血压为130/80 mmHg。超过3000万接受治疗的患者没有达到血压目标,其中约2000万患者的收缩压水平超过140 mmHg。尽管服用了两种或两种以上药物,但高血压患者仍持续存在,心血管疾病或中风导致的死亡率风险分别为1.8倍和2.5倍。在一项评估200名uHTN和rHTN(目标HTN)受试者的第2阶段临床试验中,洛龙前列素显示,每天给药一次,血压下降具有临床意义和统计学意义,且耐受性良好。除高血压外,该公司还打算开发用于治疗慢性肾脏病(CKD)的氯前列素。
发行价格:
--
{"stockData":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":12.8,"timestamp":1714593600000,"preClose":12.25,"halted":0,"volume":369927,"delay":0,"floatShares":22988299,"shares":49631159,"eps":-1.986777,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.55,"latestTime":"05-02 06:37:48 EDT","open":12.41,"high":13.53,"low":12.41,"amount":4786010.466732,"amplitude":0.091429,"askPrice":20.47,"askSize":100,"bidPrice":10.52,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.986777,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714656600000},"adr":0,"listingDate":1676005200000,"adjPreClose":12.8,"postHourTrading":{"tag":"盘后","latestPrice":12.8,"preClose":12.8,"latestTime":"16:01 EDT","volume":353,"amount":4518.4,"timestamp":1714593719985},"volumeRatio":4.568105374911603},"requestUrl":"/m/hq/s/MLYS","defaultTab":"news","newsList":[{"id":"2432835816","title":"Mineralys Therapeutics, Inc.盘中异动 快速上涨5.06%报12.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432835816","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432835816?lang=zh_cn&edition=full","pubTime":"2024-05-02 00:09","pubTimestamp":1714579771,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日00时09分,Mineralys Therapeutics, Inc.股票出现波动,股价快速上涨5.06%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。其相关个股中,Cytomx Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Psyence Biomedical Ltd.涨幅较大,Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为1321.64%、210.45%、50.45%,振幅较大的相关个股有Cytomx Therapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cassava Sciences Inc C/Wts 15/11/2024,振幅分别为188.34%、77.43%、66.20%。Mineralys Therapeutics, Inc.公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502000932861ea8dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502000932861ea8dd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429112818","title":"Mineralys Therapeutics, Inc.盘中异动 临近午盘股价大涨5.30%报11.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429112818","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429112818?lang=zh_cn&edition=full","pubTime":"2024-04-23 23:58","pubTimestamp":1713887887,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日23时58分,Mineralys Therapeutics, Inc.股票出现波动,股价快速拉升5.30%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.40%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Abvc Biopharma, Inc.涨幅较大,Palisade Bio, Inc.、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃,换手率分别为2500.31%、177.90%、42.97%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Palisade Bio, Inc.,振幅分别为80.08%、56.09%、45.43%。Mineralys Therapeutics, Inc.公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042323580887e82e15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042323580887e82e15&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427835354","title":"Mineralys Therapeutics, Inc.盘中异动 急速跳水5.00%报12.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427835354","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427835354?lang=zh_cn&edition=full","pubTime":"2024-04-16 03:54","pubTimestamp":1713210898,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日03时54分,Mineralys Therapeutics, Inc.股票出现异动,股价大幅下挫5.00%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大,Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1738.71%、1265.53%、909.78%,振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024,振幅分别为273.33%、124.89%、80.04%。Mineralys Therapeutics, Inc.公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160354597920a73d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160354597920a73d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425901349","title":"Mineralys Therapeutics, Inc.盘中异动 早盘快速上涨5.16%报13.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425901349","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425901349?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:34","pubTimestamp":1712583262,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时34分,Mineralys Therapeutics, Inc.股票出现波动,股价快速拉升5.16%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,Longeveron Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、泰坦制药涨幅较大,Allarity Therapeutics, Inc.、Longeveron Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为508.95%、337.47%、52.28%,振幅较大的相关个股有Longeveron Inc.、泰坦制药、Galmed Pharmaceuticals Ltd.,振幅分别为31.72%、16.79%、13.65%。Mineralys Therapeutics, Inc.公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821342387e7e8b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040821342387e7e8b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425569049","title":"Mineralys Therapeutics, Inc.盘中异动 早盘急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425569049","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425569049?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:31","pubTimestamp":1712327519,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日22时31分,Mineralys Therapeutics, Inc.股票出现波动,股价急速上涨5.08%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Mink Therapeutics, Inc.涨幅较大,Protara Therapeutics, Inc.、Tc Biopharm Plc、Effector Therapeutics, Inc.较为活跃,换手率分别为61.39%、33.03%、19.42%,振幅较大的相关个股有Protara Therapeutics, Inc.、Mink Therapeutics, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 ,振幅分别为40.80%、37.31%、26.53%。Mineralys Therapeutics, Inc.公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040522315987e7e2c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040522315987e7e2c2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421005682","title":"Mineralys Therapeutics, Inc.2023财年实现净利润-71.90百万美元,同比减少141.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421005682","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421005682?lang=zh_cn&edition=full","pubTime":"2024-03-22 06:19","pubTimestamp":1711059563,"startTime":"0","endTime":"0","summary":"12月31日,Mineralys Therapeutics, Inc.公布财报,公告显示公司2023财年净利润为-71.90百万美元,同比减少141.28%;其中营业收入为0.00美元,每股基本收益为-1.99美元。机构评级:截至2023年12月31日,当前有4家机构对Mineralys Therapeutics, Inc.目标价做出预测,其中目标均价为35.00美元,其中最低目标价为27.00美元,最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032206192987a3acda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032206192987a3acda&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421788950","title":"Mineralys Therapeutics, Inc.盘中异动 下午盘快速下挫5.15%报12.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421788950","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421788950?lang=zh_cn&edition=full","pubTime":"2024-03-22 02:25","pubTimestamp":1711045512,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日02时25分,Mineralys Therapeutics, Inc.股票出现异动,股价快速跳水5.15%。截至发稿,该股报12.70美元/股,成交量28.466万股,换手率0.58%,振幅7.39%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.11%。Mineralys Therapeutics, Inc.公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322022513861e02c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322022513861e02c3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420276733","title":"Mineralys Therapeutics, Inc.盘中异动 股价大涨5.39%报13.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420276733","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420276733?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:44","pubTimestamp":1710859472,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时44分,Mineralys Therapeutics, Inc.股票出现异动,股价急速上涨5.39%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.18%。其相关个股中,Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、知临集团涨幅较大,Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为803.82%、394.91%、135.78%,振幅较大的相关个股有Enveric Biosciences, Inc.、知临集团、Tracon Pharmaceuticals, Inc.,振幅分别为53.64%、49.87%、47.94%。Mineralys Therapeutics, Inc.公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319224433791b7b73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319224433791b7b73&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418339108","title":"Mineralys Therapeutics, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418339108","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418339108?lang=zh_cn&edition=full","pubTime":"2024-03-12 02:17","pubTimestamp":1710181077,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日02时17分,Mineralys Therapeutics, Inc.股票出现异动,股价大幅下跌5.09%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.27%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Tc Biopharm Plc、Celularity Inc C/Wts 16/07/2026 涨幅较大,Tc Biopharm Plc、180 Life Sciences Corp.、Transcode Therapeutics, Inc.较为活跃,换手率分别为5505.34%、194.13%、111.90%,振幅较大的相关个股有Tc Biopharm Plc、Tc Biopharm Plc C/Wts 10/02/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为152.82%、145.83%、83.63%。Mineralys Therapeutics, Inc.公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240312021757861dd23e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240312021757861dd23e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417244704","title":"Mineralys Therapeutics, Inc.盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417244704","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417244704?lang=zh_cn&edition=full","pubTime":"2024-03-07 04:09","pubTimestamp":1709755769,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日04时09分,Mineralys Therapeutics, Inc.股票出现异动,股价大幅跳水5.00%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,知临集团、Nkgen Biotech Inc C/Wts 31/05/2028、Biomx Inc.涨幅较大,知临集团、Nkgen Biotech, Inc.、Biomx Inc.较为活跃,换手率分别为1523.71%、471.22%、295.36%,振幅较大的相关个股有知临集团、Nkgen Biotech, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为1024.76%、336.43%、255.70%。Mineralys Therapeutics, Inc.公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307040930861dbe2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307040930861dbe2a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415301657","title":"Mineralys Therapeutics Inc盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415301657","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415301657?lang=zh_cn&edition=full","pubTime":"2024-02-29 03:01","pubTimestamp":1709146889,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日03时01分,Mineralys Therapeutics Inc股票出现波动,股价大幅跳水5.00%。Mineralys Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.71%。其相关个股中,Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc涨幅较大,Adial Pharmaceuticals Inc、Vivani Medical Inc、Revelation Biosciences Inc较为活跃,换手率分别为6248.65%、237.07%、144.58%,振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc,振幅分别为424.75%、219.84%、129.29%。Mineralys Therapeutics Inc公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229030129861d9b28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229030129861d9b28&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411689533","title":"Mineralys Therapeutics Inc盘中异动 快速下跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411689533","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411689533?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:31","pubTimestamp":1707834689,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时31分,Mineralys Therapeutics Inc股票出现异动,股价急速下跌5.50%。Mineralys Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.66%。其相关个股中,Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大,Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃,换手率分别为295.55%、81.29%、29.63%,振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Biovie Inc、Rhythm Pharmaceuticals Inc,振幅分别为12.41%、12.28%、10.90%。Mineralys Therapeutics Inc公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402132231298188eae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402132231298188eae6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410052826","title":"Mineralys Therapeutics Inc盘中异动 早盘快速拉升5.06%报14.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410052826","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410052826?lang=zh_cn&edition=full","pubTime":"2024-02-09 23:40","pubTimestamp":1707493205,"startTime":"0","endTime":"0","summary":"北京时间2024年02月09日23时40分,Mineralys Therapeutics Inc股票出现异动,股价大幅拉升5.06%。截至发稿,该股报14.74美元/股,成交量5.7261万股,换手率0.14%,振幅4.95%。Mineralys Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.79%。Mineralys Therapeutics Inc公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209234006791098db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209234006791098db&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409120847","title":"Mineralys Therapeutics Inc股价上涨17.28% 市值涨1.04亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409120847","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409120847?lang=zh_cn&edition=full","pubTime":"2024-02-08 22:31","pubTimestamp":1707402715,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日22时31分,Mineralys Therapeutics Inc股票出现波动,股价快速上涨17.28%。Mineralys Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Mineralys Therapeutics Inc、Foghorn Therapeutics Inc涨幅较大,Tenax Therapeutics Inc、Biodexa Pharmaceuticals Plc、Invivo Therapeutics Holding Corp较为活跃,换手率分别为356.36%、24.52%、21.58%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Keros Therapeutics Inc、Replimune Group Inc,振幅分别为29.82%、12.82%、10.44%。Mineralys Therapeutics Inc公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223155817a4343&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223155817a4343&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408653128","title":"Mineralys Therapeutics Inc盘中异动 股价大涨5.87%报11.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408653128","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408653128?lang=zh_cn&edition=full","pubTime":"2024-02-02 00:14","pubTimestamp":1706804067,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日00时14分,Mineralys Therapeutics Inc股票出现波动,股价急速上涨5.87%。Mineralys Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,Gri Bio Inc、Neurobo Pharmaceuticals Inc、Kiora Pharmaceuticals Inc涨幅较大,Gri Bio Inc、Neurobo Pharmaceuticals Inc、Revelation Biosciences Inc较为活跃,换手率分别为1365.91%、994.84%、895.17%,振幅较大的相关个股有Gri Bio Inc、Neurobo Pharmaceuticals Inc、Ys Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为207.75%、64.22%、63.06%。Mineralys Therapeutics Inc公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202001428861d0562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202001428861d0562&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407867139","title":"Mineralys Therapeutics Inc盘中异动 急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407867139","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407867139?lang=zh_cn&edition=full","pubTime":"2024-01-29 22:31","pubTimestamp":1706538714,"startTime":"0","endTime":"0","summary":"北京时间2024年01月29日22时31分,Mineralys Therapeutics Inc股票出现波动,股价急速跳水5.05%。Mineralys Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,Palisade Bio Inc、Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences Inc涨幅较大,Revelation Biosciences Inc、Panbela Therapeutics Inc、Palisade Bio Inc较为活跃,换手率分别为695.65%、524.10%、403.39%,振幅较大的相关个股有Palisade Bio Inc、Revelation Biosciences Inc、Conduit Pharmaceuticals Inc,振幅分别为40.38%、18.24%、14.21%。Mineralys Therapeutics Inc公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012922315487e6962e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012922315487e6962e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406580243","title":"Mineralys Therapeutics Inc盘中异动 早盘急速拉升5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406580243","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406580243?lang=zh_cn&edition=full","pubTime":"2024-01-25 23:43","pubTimestamp":1706197423,"startTime":"0","endTime":"0","summary":"北京时间2024年01月25日23时43分,Mineralys Therapeutics Inc股票出现波动,股价大幅拉升5.49%。Mineralys Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Processa Pharmaceuticals Inc、Onconetix Inc、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Processa Pharmaceuticals Inc、Onconetix Inc、Lava Therapeutics Nv较为活跃,换手率分别为3430.28%、425.47%、121.29%,振幅较大的相关个股有Processa Pharmaceuticals Inc、Onconetix Inc、Clearmind Medicine Inc,振幅分别为109.27%、83.38%、46.98%。Mineralys Therapeutics Inc公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125234344861cdcd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125234344861cdcd9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406442434","title":"Mineralys Therapeutics Inc盘中异动 大幅上涨5.08%报9.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406442434","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406442434?lang=zh_cn&edition=full","pubTime":"2024-01-25 01:54","pubTimestamp":1706118842,"startTime":"0","endTime":"0","summary":"北京时间2024年01月25日01时54分,Mineralys Therapeutics Inc股票出现异动,股价大幅拉升5.08%。截至发稿,该股报9.93美元/股,成交量4.0434万股,换手率0.10%,振幅6.19%。Mineralys Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.65%。Mineralys Therapeutics Inc公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125015402861cd543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125015402861cd543&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405510747","title":"Mineralys Therapeutics Inc盘中异动 临近收盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2405510747","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405510747?lang=zh_cn&edition=full","pubTime":"2024-01-24 04:43","pubTimestamp":1706042606,"startTime":"0","endTime":"0","summary":"北京时间2024年01月24日04时43分,Mineralys Therapeutics Inc股票出现异动,股价急速上涨5.03%。Mineralys Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Dermata Therapeutics Inc C/Wts 13/08/2026 、Ensysce Biosciences Inc、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大,Ensysce Biosciences Inc、Transcode Therapeutics Inc、Kintara Therapeutics Inc较为活跃,换手率分别为1275.45%、225.72%、58.11%,振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Clene Inc C/Wts 30/12/2025 ,振幅分别为111.11%、70.54%、69.31%。Mineralys Therapeutics Inc公司简介:Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240124044327790b79b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240124044327790b79b0&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mineralystx.com","stockEarnings":[{"period":"1week","weight":0.1268},{"period":"1month","weight":-0.0177},{"period":"3month","weight":0.0079},{"period":"6month","weight":0.5403},{"period":"1year","weight":-0.054},{"period":"ytd","weight":0.4884}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mineralys Therapeutics, Inc.最初成立于2019年5月31日,是特拉华州的一家公司。该公司是一家临床阶段生物制药公司,专注于开发药物,以治疗由异常升高的醛固酮引起的疾病。该公司的候选产品氯隆前列素是一种专有的口服高选择性醛固酮合酶抑制剂(ASI),该公司最初开发用于治疗未控制的高血压(uHTN)患者,定义为尽管服用了两种或多种抗高血压药物或抵抗性高血压(rHTN),但血压仍不能达到130/80mmHg以下的个体。在美国,有超过1.15亿患者患有持续性高血压(BP)或高血压,超过一半的患者未能实现血压目标,即目前可用的药物血压为130/80 mmHg。超过3000万接受治疗的患者没有达到血压目标,其中约2000万患者的收缩压水平超过140 mmHg。尽管服用了两种或两种以上药物,但高血压患者仍持续存在,心血管疾病或中风导致的死亡率风险分别为1.8倍和2.5倍。在一项评估200名uHTN和rHTN(目标HTN)受试者的第2阶段临床试验中,洛龙前列素显示,每天给药一次,血压下降具有临床意义和统计学意义,且耐受性良好。除高血压外,该公司还打算开发用于治疗慢性肾脏病(CKD)的氯前列素。","exchange":"NASDAQ","name":"Mineralys Therapeutics, Inc.","nameEN":"Mineralys Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mineralys Therapeutics, Inc.(MLYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mineralys Therapeutics, Inc.(MLYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mineralys Therapeutics, Inc.,MLYS,Mineralys Therapeutics, Inc.股票,Mineralys Therapeutics, Inc.股票老虎,Mineralys Therapeutics, Inc.股票老虎国际,Mineralys Therapeutics, Inc.行情,Mineralys Therapeutics, Inc.股票行情,Mineralys Therapeutics, Inc.股价,Mineralys Therapeutics, Inc.股市,Mineralys Therapeutics, Inc.股票价格,Mineralys Therapeutics, Inc.股票交易,Mineralys Therapeutics, Inc.股票购买,Mineralys Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mineralys Therapeutics, Inc.(MLYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mineralys Therapeutics, Inc.(MLYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}